Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hider

Showing results (531-540 of 598) with videos related to

Pageof 60
Sort By:
Bioorganic & Medicinal Chemistry Letters|May 18, 2016
Design and synthesis of novel hydroxypyridinone derivatives as potential tyrosinase inhibitorsDe-Yin Zhao, Ming-Xia Zhang, Xiao-Wu Dong, et al.
Surgery|May 11, 2015
Toward a standard approach to measurement and reporting of perioperative mortality rate as a global indicator for surgeryRoshan Ariyaratnam, Charlotta L Palmqvist, Phil Hider, et al.
European Heart Journal|April 26, 2003
Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised studyS Tonstad, C Farsang, G Klaene, et al.
Agents and Actions|September 1, 1993
The effect of a synthetic hexadentate iron chelator (CP130) and desferrioxamine on rabbit kidneys exposed to cold and warm ischaemiaJ D Gower, I J Ambrose, S Manek, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|February 8, 2018
Soft, adhesive (+) alpha tocopherol phosphate planar bilayers that control oral biofilm growth through a substantive antimicrobial effectRobert A Harper, Mais M Saleh, Guy Carpenter, et al.
Journal of Hepatology|June 5, 2002
Aceruloplasminemia: new clinical, pathophysiological and therapeutic insightsOlivier Loréal, Bruno Turlin, Christelle Pigeon, et al.
Rheumatology Advances in Practice|January 12, 2023
Digital exclusion as a potential cause of inequalities in access to care: a survey in people with inflammatory rheumatic diseasesSamantha Hider, Sara Muller, Lauren Gray, et al.
Pharmacogenetics and Genomics|July 14, 2011
Genetic epidemiology of induced CYP3A4 activityNilufer Rahmioglu, James Heaton, Gail Clement, et al.
Rheumatology (Oxford, England)|December 22, 2022
Factors associated with change in health-related quality of life in people with gout: a 3-year prospective cohort study in primary careLorraine Watson, John Belcher, Elaine Nicholls, et al.
Dalton Transactions (Cambridge, England : 2003)|March 13, 2019
Tuning the properties of tris(hydroxypyridinone) ligands: efficient <sup>68</sup>Ga chelators for PET imagingCinzia Imberti, Yu-Lin Chen, Calum A Foley, et al.
Pageof 60

Showing results (531-540 of 598) with videos related to

Sort By:
Pageof 60
Bioorganic & Medicinal Chemistry Letters|May 18, 2016
Design and synthesis of novel hydroxypyridinone derivatives as potential tyrosinase inhibitorsDe-Yin Zhao, Ming-Xia Zhang, Xiao-Wu Dong, et al.
Surgery|May 11, 2015
Toward a standard approach to measurement and reporting of perioperative mortality rate as a global indicator for surgeryRoshan Ariyaratnam, Charlotta L Palmqvist, Phil Hider, et al.
European Heart Journal|April 26, 2003
Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised studyS Tonstad, C Farsang, G Klaene, et al.
Agents and Actions|September 1, 1993
The effect of a synthetic hexadentate iron chelator (CP130) and desferrioxamine on rabbit kidneys exposed to cold and warm ischaemiaJ D Gower, I J Ambrose, S Manek, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|February 8, 2018
Soft, adhesive (+) alpha tocopherol phosphate planar bilayers that control oral biofilm growth through a substantive antimicrobial effectRobert A Harper, Mais M Saleh, Guy Carpenter, et al.
Journal of Hepatology|June 5, 2002
Aceruloplasminemia: new clinical, pathophysiological and therapeutic insightsOlivier Loréal, Bruno Turlin, Christelle Pigeon, et al.
Rheumatology Advances in Practice|January 12, 2023
Digital exclusion as a potential cause of inequalities in access to care: a survey in people with inflammatory rheumatic diseasesSamantha Hider, Sara Muller, Lauren Gray, et al.
Pharmacogenetics and Genomics|July 14, 2011
Genetic epidemiology of induced CYP3A4 activityNilufer Rahmioglu, James Heaton, Gail Clement, et al.
Rheumatology (Oxford, England)|December 22, 2022
Factors associated with change in health-related quality of life in people with gout: a 3-year prospective cohort study in primary careLorraine Watson, John Belcher, Elaine Nicholls, et al.
Dalton Transactions (Cambridge, England : 2003)|March 13, 2019
Tuning the properties of tris(hydroxypyridinone) ligands: efficient <sup>68</sup>Ga chelators for PET imagingCinzia Imberti, Yu-Lin Chen, Calum A Foley, et al.
Pageof 60